A 58-year-old man with newly diagnosed type 2 diabetes, obesity, and dyslipidaemia has an LDL cholesterol of 3.1 mmol/L and no known cardiovascular disease. His 10-year cardiovascular risk is calculated as high. He has no contraindications to statin therapy. According to current Canadian guidance, what is the most appropriate lipid management strategy?